Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Awards $300,000 per recipient for business, city or township governments, county governments, for profit organizations other than small businesses, independent school districts, individual, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofit, nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, other legal entity, private institutions of higher education, public agency, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments, tribal government, unrestricted, closing Forecasted — not yet open.
In one sentence
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed awards $300,000 per recipient, open to business, city or township governments, county governments, for profit organizations other than small businesses,…
- Program pool (total)
- $300,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- $300,000Award floor and ceiling are both $300,000; expected number of awards is 1
- Award floor
- $300,000
- Typical award
- $300,000
- Deadline
- Forecasted — not yet open
- Deadline type
- forecasted
- Opens
- Not stated
- Status
- Forecasted
- Eligible entities
- Business · City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Individual · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofit · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Other Legal Entity · Private institutions of higher education · Public Agency · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments · Tribal Government · Unrestricted
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Source wording: “Award floor and ceiling are both $300,000; expected number of awards is 1”
Who can apply?
Business, City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Individual, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofit, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Other Legal Entity, Private institutions of higher education, Public Agency, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments, Tribal Government, Unrestricted
Source field: entity typesAgriculture, Consumer Protection, Food and Nutrition
Source field: industriesAssessment of biological activity of diastereomers in inhibiting PCSK9 activity, Assessment of individual contribution of each diastereomer to overall pharmacological activity, Development of analytical methods to identify and characterize stereochemical structure of diastereomers, Synthesis of diastereomers of LEQVIO (Inclisiran)
Source field: use of fundsNot stated
Source field: applicant size limitApplicant organizations may submit more than one application, provided that each application is scientifically distinct. The FDA will not accept duplicate or highly overlapping applications under review at the same time per 2.3.7.4 Submission of Resubmission Application. This means that the NIH or FDA will not accept: A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application. A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application. An application that has substantial overlap with another application pending appeal of initial peer review.
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- NoCost sharing: false
Who has received this funding?
No award records yet
We hold no prior awards for this programme. That is a gap in what we have connected, not a finding that the programme has never funded anyone — check the official page, which may list past recipients.
Common questions
Every answer below is a stored field from this record. Questions the source did not answer are not asked.
- How much can one applicant receive?
- $300,000 per recipient. The source states: “Award floor and ceiling are both $300,000; expected number of awards is 1”.
- How much funding is available in total?
- $300,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- Who is eligible to apply?
- Business, City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Individual, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofit, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Other Legal Entity, Private institutions of higher education, Public Agency, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments, Tribal Government, Unrestricted.
- What can the funding be used for?
- Synthesis of diastereomers of LEQVIO (Inclisiran), Assessment of biological activity of diastereomers in inhibiting PCSK9 activity, Development of analytical methods to identify and characterize stereochemical structure of diastereomers, Assessment of individual contribution of each diastereomer to overall pharmacological activity, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required. Cost sharing: false
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.